We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Protein Discovery Adds Director of Mass Spectrometry to Scientific Staff

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Protein Discovery, Inc. has announced that Jeremy Norris, Ph.D., an imaging mass spectrometry expert, has joined the company as director of mass spectrometry.

Dr. Norris will be responsible for the company’s tissue imaging and profiling mass spectrometry service.

Prior to joining Protein Discovery, Dr. Norris was an adjunct instructor of biochemistry at Vanderbilt University, where he also received his doctor of philosophy degree in Chemistry under the guidance of Professor Richard M. Caprioli.

While at Vanderbilt University, Dr. Norris was responsible for all internal operations related to the University’s tissue imaging work for outside companies and shared responsibility for designing and implementing the University’s Serum Proteomics Core.

Dr. Norris has produced dozens of presentations, book chapters, patents, and publications related to imaging mass spectrometry and proteomics in general.

"It has been my privilege to be closely involved in the development and advancement of imaging mass spectrometry and its diagnostic and prognostic potential," said Dr. Norris.

"The director of mass spectrometry position at Protein Discovery will enable me to take this exciting technology to the next level—commercial deployment into diverse research and clinical settings."

Protein Discovery, Inc. has retained exclusive worldwide licenses from Vanderbilt University to provide commercial imaging mass spectrometry services and to develop associated sample preparation products.

Protein Discovery has also retained rights from the University of Texas to perform the imaging services.

This intellectual property portfolio provides the company with the exclusive rights to provide imaging mass spectrometry services for preclinical purposes.